The number of patients undergoing prostate biopsy has increased due to the widespread use of prostate-speci®c antigen (PSA). The low speci®city of PSA requires prostate biopsy for diagnosis of prostate cancer. The sextant biopsy technique had been used wid`ely to diagnose prostate cancer. However, concern has arisen that this method may not include an adequate sampling of the prostate, especially for large prostate volumes. We conducted a prospective study in patients with PSA levels 10 ngaml to determine the in¯uence of the total and transition zone (TZ) volumes of the prostate and different PSA parameters for predicting whether one single set of biopsies was suf®cient to rule out prostate cancer. These different parameters were evaluated in patients in whom prostate cancer was found after one set of biopsies and those in whom it was found after the second set.
Method
A total of 1018 patients were prospectively included in this study. All underwent transrectal ultrasound guided needle sextant and two transition zone biopsies of the prostate and the total and TZ volumes of the prostate were measured (prolate ellipsoid method). From this cohort, all patients in whom a benign disease was identi®ed after the ®rst set of biopsies underwent a second similar set of biopsies within 6 weeks. Serum PSA and percent PSA were measured (Axsym, Abbott) and the PSA density of the whole prostate (PSAD) and of the transition zone (PSA-TZ) were calculated. Only patients with prostate cancer were included in this study, whether diagnosed after the ®rst or second set of biopsies. Statistical analysis using the SAS system (CARY, North Carolina) and ROC curves were used to compare patients in whom the diagnosis was performed after the ®rst set of biopsies and those who required a second set.
Results
Of the 1018 patients, 354 had prostate cancer diagnosed; 284 after the ®rst set of biopsies and 60 after the second. Table 1 shows the differences in PSA and volume parameters between the two subgroups. Mean AE standard deviations are presented t-Test values`0.05 are statistically signi®cant.
ROC curves showed that total and TZ volumes of 40 and 19.5 cm 3 , respectively, provided the best combination of sensitivity and speci®city for discriminating between patients diagnosed with prostate cancer after the ®rst and second set.
Conclusion
In patients with total prostate volume above 40 cm 3 and TZ above 20 cm 3 , a single set of sextant biopsies may not be suf®cient to rule out prostate cancer. In these patients, a second set of biopsies should be considered. 
